Roquefort Therapeutics plc (ROQ.L)
GBp 1.7
(0.0%)
GBp 1.7
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -537.32 Thousand GBP | 76.87% |
| 2022 | -2.32 Million GBP | -158.19% |
| 2021 | -899.72 Thousand GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 14.03 Thousand GBP | 102.61% |
| 2024 Q2 | 14.03 Thousand GBP | 0.0% |
| 2023 Q4 | -537.32 Thousand GBP | 0.0% |
| 2023 FY | -537.32 Thousand GBP | 76.87% |
| 2023 Q3 | -537.32 Thousand GBP | 61.04% |
| 2023 Q2 | -1.37 Million GBP | 0.0% |
| 2023 Q1 | -1.37 Million GBP | 40.64% |
| 2022 Q3 | -2.32 Million GBP | 30.21% |
| 2022 Q2 | -3.32 Million GBP | 0.0% |
| 2022 FY | -2.32 Million GBP | -158.19% |
| 2022 Q4 | -2.32 Million GBP | 0.0% |
| 2022 Q1 | -3.32 Million GBP | -269.96% |
| 2021 Q2 | -880.44 Thousand GBP | 0.0% |
| 2021 Q4 | -899.72 Thousand GBP | 0.0% |
| 2021 FY | -899.72 Thousand GBP | 0.0% |
| 2021 Q1 | -880.44 Thousand GBP | -665.61% |
| 2020 Q3 | -114.99 Thousand GBP | 0.0% |
| 2020 Q4 | -114.99 Thousand GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|